EUVIMEDEUVIMED entdecken
Systematische ÜbersichtLeitlinieOpen Access

2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases

Anne R Bass iD, Eliza Chakravarty, Elie A Akl, Clifton O Bingham iD, Leonard Calabrese iD, Laura C Cappelli iD, Sindhu R Johnson iD, Lisa F Imundo, Kevin L Winthrop iD, Reuben J Arasaratnam, Lindsey R Baden, Roberta Berard iD und 29 weitere

Arthritis & Rheumatology · 2023-03 · 75 (3) · 333-348

DOI: 10.1002/art.42386 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Arthritis & Rheumatology, online erschienen am 04.01.2023. Verfasst von Anne R Bass und 40 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Special Surgery and Weill Cornell Medicine, New York, New York. Hauptthemen laut MEDLINE: Rheumatology, Antirheumatic Agents, Musculoskeletal Diseases. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To provide evidence‐based recommendations on the use of vaccinations in children and adults with rheumatic and musculoskeletal diseases (RMDs).

Methods

This guideline follows American College of Rheumatology (ACR) policy guiding management of conflicts of interest and disclosures and the ACR guideline development process, which includes the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. It also adheres to the Appraisal of Guidelines for Research and Evaluation (AGREE) criteria. A core leadership team consisting of adult and pediatric rheumatologists and a guideline methodologist drafted clinical population, intervention, comparator, outcomes (PICO) questions. A review team performed a systematic literature review for the PICO questions, graded the quality of evidence, and produced an evidence report. An expert Voting Panel reviewed the evidence and formulated recommendations. The panel included adult and pediatric rheumatology providers, infectious diseases specialists, and patient representatives. Consensus required ≥70% agreement on both the direction and strength of each recommendation.

Results

This guideline includes expanded indications for some vaccines in patients with RMDs, as well as guidance on whether to hold immunosuppressive medications or delay vaccination to maximize vaccine immunogenicity and efficacy. Safe approaches to the use of live attenuated vaccines in patients taking immunosuppressive medications are also addressed. Most recommendations are conditional and had low quality of supporting evidence.

Conclusion

Application of these recommendations should consider patients’ individual risk for vaccine‐preventable illness and for disease flares, particularly if immunosuppressive medications are held for vaccination. Shared decision‐making with patients is encouraged in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RheumatologyAntirheumatic AgentsMusculoskeletal DiseasesChildHumansUnited StatesVaccination

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Hospital for Special Surgery and Weill Cornell Medicine, New York, New York.
  • Oklahoma Medical Research Foundation, Oklahoma City.
  • American University of Beirut, Beirut, Lebanon.
  • Johns Hopkins Medicine, Baltimore, Maryland.
  • Cleveland Clinic Foundation, Cleveland, Ohio.
  • Toronto Western Hospital, Mount Sinai Hospital, and University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Anne R Bass, Clifton O Bingham, Leonard Calabrese, Laura C Cappelli, Sindhu R Johnson, Kevin L Winthrop, Roberta Berard, S Louis Bridges, Jeffrey R Curtis, Benjamin J Smith, Jeffrey A Sparks, Tiphanie P Vogel, Elena Gkrouzman, Kimberly S Lakin, Mindy S Lo, Megan M Lockwood, Rebecca E Sadun, Herman Tam, Amy S Turner

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Bass, A. R., Chakravarty, E., Akl, E. A., Bingham, C. O., Calabrese, L., Cappelli, L. C., Johnson, S. R., Imundo, L. F., Winthrop, K. L., Arasaratnam, R. J., Baden, L. R., Berard, R., Bridges, S. L., Cheah, J. T. L., Curtis, J. R., Ferguson, P. J., Hakkarinen, I., Onel, K. B., Schultz, G., …, & Reston, J. (2023). 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis & Rheumatology, 75(3), 333-348. https://doi.org/10.1002/art.42386

Vancouver

Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, et al. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis & Rheumatology. 2023;75(3):333-348. doi:10.1002/art.42386

BibTeX
@article{Bass2023,
  author = {Bass, Anne R and Chakravarty, Eliza and Akl, Elie A and Bingham, Clifton O and Calabrese, Leonard and Cappelli, Laura C and Johnson, Sindhu R and Imundo, Lisa F and Winthrop, Kevin L and Arasaratnam, Reuben J and Baden, Lindsey R and Berard, Roberta and Bridges, S Louis and Cheah, Jonathan T L and Curtis, Jeffrey R and Ferguson, Polly J and Hakkarinen, Ida and Onel, Karen B and Schultz, Grayson and Sivaraman, Vidya and Smith, Benjamin J and Sparks, Jeffrey A and Vogel, Tiphanie P and Williams, Eleanor Anderson and Calabrese, Cassandra and Cunha, Joanne S and Fontanarosa, Joann and Gillispie-Taylor, Miriah C and Gkrouzman, Elena and Iyer, Priyanka and Lakin, Kimberly S and Legge, Alexandra and Lo, Mindy S and Lockwood, Megan M and Sadun, Rebecca E and Singh, Namrata and Sullivan, Nancy and Tam, Herman and Turgunbaev, Marat and Turner, Amy S and Reston, James},
  title = {2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases},
  journal = {Arthritis & Rheumatology},
  year = {2023},
  volume = {75},
  number = {3},
  pages = {333--348},
  doi = {10.1002/art.42386}
}
Kostenlos starten →